Definitive Healthcare
DH | NASDAQ
$1.26
-$0.05 (-3.82%)
At close: Nov 16, 2026, 4:00 PM ET
$1.28
+$0.02 (+1.59%)
After-hours:
Nov 16, 2026, 6:06 PM ET
Definitive Healthcare Company Profile
Company profile explainedCompany Profile
Definitive Healthcare Corp. (DH), operating through its various subsidiaries, offers specialized commercial intelligence solutions for the U.S. healthcare industry. The company's services furnish essential data on healthcare providers and their activities, enabling clients to navigate critical business processes, from the early stages of product development to strategic market entry planning and effective sales and marketing execution. Its sophisticated platform incorporates sixteen distinct intelligence modules. These modules are designed to support key functional domains such as sales optimization, marketing initiatives, clinical research, new product creation, strategic planning, human capital acquisition, and the oversight of physician networks. Definitive Healthcare caters to a broad spectrum of clients, including biopharmaceutical firms, medical device manufacturers, healthcare information technology companies, and direct healthcare providers. Additionally, its clientele extends to diverse organizations within the wider healthcare ecosystem, such as staffing and commercial real estate companies, financial institutions, and other related entities. Founded in 2011, Definitive Healthcare Corp. is headquartered in Framingham, Massachusetts.
Key Executives
| Name | Position |
|---|---|
| Clay Ritchey | Chief Executive Officer & Director |
| Kevin D. Coop | Chief Executive Officer & Director |
| Casey Heller | Chief Financial Officer |
| Jonathan Paris | Chief Legal Officer & Secretary |
| Jason Ronald Krantz | Founder & Executive Chairman |
| Jeannine Lombardi Sheehan | Chief Human Resources Officer |
| Marissa Peoples Odell | SVP & Head of Sales |
| Rebecca Marani | Chief Product Officer |
| Sally Slarke | Senior Vice President of Commercial Center of Excellence |
| Srinivas Attipalli | Senior VP and Head of AI & Data - Product |
| Tina Hannagan | Chief Commercial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 27, 2026 | 4 | Filing |
| Oct 05, 2026 | 4 | Filing |
| Oct 05, 2026 | 4 | Filing |
| Oct 01, 2026 | SC 13D/A | [Amend] Filing |
| Sep 16, 2026 | 3 | Filing |
| Sep 09, 2026 | 8-K | Current Report |
| Sep 03, 2026 | 4 | Filing |
| Sep 02, 2026 | 8-K | Current Report |
| Sep 02, 2026 | SC 13D | Filing |
| Sep 02, 2026 | 8-K | Current Report |
Definitive Healthcare
| Country | United States |
| IPO Date | Sep 15, 2021 |
| Industry | Medical - Healthcare Information Services |
| Sector | Healthcare |
| Employees | 682 |
| CEO | Clay Ritchey |
Contact Details
492 Old Connecticut Path Framingham,
Massachusetts 01701 United States
Stock Details
| Ticker Symbol | DH |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001861795 |
| CUSIP Number | 24477E103 |
| ISIN Number | US24477E1038 |
| SIC Code | 7372 |
Add to Watchlist
Select watchlists to add or remove DH